Eraxis FDA Approval History
FDA Approved: Yes (First approved February 17, 2006)
Brand name: Eraxis
Generic name: anidulafungin
Dosage form: Injection
Company: Pfizer Inc.
Treatment for: Candidemia
Eraxis (anidulafungin) is an antifungal medicine of the echinocandin class, indicated for the treatment of candidemia and other forms of Candida infections (intra-abdominal abscess, and peritonitis) and esophageal candidiasis.
Development Timeline for Eraxis
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.